Kevin McLaughlin

Mr. McLaughlin has more than 40 years of financial and operating management experience spanning the biotech, high-tech and education industries. From 2010 to 2021, he served as Senior Vice President, Chief Financial Officer and Treasurer of Acceleron Pharma until its acquisition by Merck & Co., Inc. in December 2021. Prior to Acceleron, he was SVP and CFO of Qteros, Inc., a cellulosic biofuels company from 2009 through 2010 and was co-founder, Chief Operating Officer and director of Aptius Education, Inc., a publishing company, from 2007 through 2009. From 1996 through 2007, Mr. McLaughlin held several executive positions with PRAECIS Pharmaceuticals. He joined the company as their first CFO later becoming Chief Operating Officer, and then President and Chief Executive Officer and a member of the Board of Directors. In this capacity he was responsible for negotiating the sale of the company to GSK plc (formerly GlaxoSmithKline). Mr. McLaughlin currently serves on the boards of Stealth Bio Therapeutics and Vericel Corporation. He began his career in senior financial roles at Prime Computer and Computervision Corporation. Mr. McLaughlin received a bachelor’s degree from Northeastern University and an MBA from Babson F.W. Olin Graduate School of Business.